AgeX Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.24 Insider Own0.10% Shs Outstand37.94M Perf Week-1.25%
Market Cap26.60M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float21.45M Perf Month-9.43%
Income-9.30M PEG- EPS next Q- Inst Own17.80% Short Float1.23% Perf Quarter13.84%
Sales0.14M P/S184.71 EPS this Y16.70% Inst Trans-1.03% Short Ratio4.87 Perf Half Y8.30%
Book/sh-0.30 P/B- EPS next Y- ROA-343.00% Target Price- Perf Year-38.58%
Cash/sh0.01 P/C66.49 EPS next 5Y- ROE89.40% 52W Range0.52 - 1.77 Perf YTD-28.44%
Dividend- P/FCF- EPS past 5Y12.10% ROI-566.60% 52W High-55.93% Beta1.42
Dividend %- Quick Ratio0.20 Sales past 5Y-38.70% Gross Margin- 52W Low51.10% ATR0.11
Employees5 Current Ratio0.20 Sales Q/Q-82.90% Oper. Margin- RSI (14)50.21 Volatility18.44% 12.14%
OptionableNo Debt/Eq- EPS Q/Q-35.10% Profit Margin- Rel Volume1.21 Prev Close0.70
ShortableYes LT Debt/Eq- EarningsMay 13 AMC Payout- Avg Volume54.30K Price0.78
Recom- SMA201.60% SMA50-5.95% SMA200-6.54% Volume65,946 Change11.43%
May-18-22 08:30AM  
May-13-22 04:05PM  
Mar-29-22 04:05PM  
Dec-14-21 08:30AM  
Nov-30-21 08:30AM  
Nov-23-21 04:05PM  
Nov-12-21 04:05PM  
Aug-13-21 04:05PM  
Jul-23-21 04:15PM  
May-17-21 04:05PM  
Mar-31-21 04:05PM  
Mar-12-21 08:00AM  
Mar-10-21 08:00AM  
Mar-02-21 08:00AM  
Feb-02-21 11:24PM  
Dec-22-20 03:08PM  
Nov-27-20 04:13PM  
Nov-16-20 04:05PM  
Oct-28-20 08:00AM  
Sep-15-20 07:59AM  
Sep-09-20 08:00AM  
Aug-14-20 04:05PM  
Aug-07-20 07:02AM  
Jun-16-20 08:00AM  
Jun-05-20 04:15PM  
Jun-02-20 08:00AM  
May-29-20 08:00AM  
May-21-20 08:30AM  
May-14-20 04:05PM  
May-01-20 08:54AM  
Mar-30-20 05:40PM  
Mar-20-20 09:00AM  
Feb-28-20 08:00AM  
Feb-09-20 09:12AM  
Feb-03-20 08:00AM  
Jan-29-20 08:00AM  
Jan-14-20 08:00AM  
Dec-26-19 08:00AM  
Dec-10-19 08:00AM  
Dec-09-19 07:00AM  
Nov-14-19 04:00PM  
Nov-13-19 09:50AM  
Nov-11-19 05:28AM  
Nov-08-19 06:58PM  
Oct-30-19 08:00AM  
Oct-11-19 08:00AM  
Sep-10-19 08:00AM  
Sep-09-19 07:00AM  
Sep-04-19 08:00AM  
Aug-14-19 05:16PM  
Aug-05-19 05:14PM  
Jul-09-19 08:00AM  
May-15-19 04:05PM  
May-01-19 08:00AM  
Apr-05-19 08:00AM  
Apr-01-19 04:48PM  
Mar-22-19 07:00AM  
Mar-21-19 07:00AM  
Mar-07-19 07:00AM  
Feb-14-19 08:00AM  
Jan-31-19 08:00AM  
Jan-22-19 08:00AM  
Jan-10-19 08:00AM  
Jan-09-19 08:00AM  
Jan-04-19 08:00AM  
Jan-02-19 07:00AM  
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550, a gene delivery technology. The company has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEST MICHAEL DChief Executive OfficerMar 11Option Exercise0.003,125041,696Mar 15 08:14 PM
WEST MICHAEL DChief Executive OfficerDec 11Option Exercise0.003,125039,652Dec 14 07:17 PM
WEST MICHAEL DChief Executive OfficerSep 11Option Exercise0.003,125037,608Sep 21 09:14 PM
WEST MICHAEL DChief Executive OfficerJun 11Option Exercise0.003,125035,564Jun 15 09:12 PM